]>
IRCT2017090812897N3 IRCT 2017-10-07 Qazvin University of Medical Sciences The effect of yeast probiotic (saccharomyces boulardii) on acute diarrhea in children yeast probiotic (saccharomyces boulardii) and acute diarrhea The effect of yeast probiotic (saccharomyces boulardii) on acute diarrhea in children 2017-11-22 anticipated 60 Complete https://irct.ir/trial/12898 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. N/A Acute diarrhea. Intervention 1: The case group will be receive cap Yomogi (contains 250 mg dried yeast Saccharomyces boulardii) as a single dose per day. Cap Yomogi is produced by ARDEYPHARM GmbH company under the license No. 640920, Herdecke , Germany. For easier eating of probiotics the content of cap yomogi will be dissolved in 10 ml of water. Intervention 2: The control group will receive Chickpea flour powder as a single dose per day. Chickpea flour powder is produced by Tarkhineh Company under the license No. 640920 and Operation license No.81, Tehran, Iran. For easier eating, the Chickpea flour powder will be dissolved in 10 ml of water. The color ,taste and volume of Chickpea flour powder will be similar of cap Yomogi.
public Abolfazl Mahyar
Valiasr Square-Qods Hospital
Qazvin Iran (Islamic Republic of) 3415914595 +98 28 3334 4087 amahyar@qums.ac.ir Qazvin University of Medical Sciences, Qazvin scientific Abolfazl Mahyar
Valiasr Square-Qods Hospital
Qazvin Iran (Islamic Republic of) 3415914595 +98 28 3334 4087 amahyar@qums.ac.ir Qazvin University of Medical Siences Iran (Islamic Republic of) inclusion criteria: existence of acute diarrhea; mild and moderate dehydration; age between 2-5 years ; Failure to receive antibiotics and probiotic compounds in the past 1 month . Exclusion creteria: chronic diarrhea; malabsorption diseases ;dysentery;accompanying diseasesuch as diabetes; severe dehydration ;abdominal distention; suspected to intestinal obstruction; vomiting ) 2 years 5 years Both A03 Shigellosis Treatment - Drugs Treatment - Drugs The case group will be receive cap Yomogi (contains 250 mg dried yeast Saccharomyces boulardii) as a single dose per day. Cap Yomogi is produced by ARDEYPHARM GmbH company under the license No. 640920, Herdecke , Germany. For easier eating of probiotics the content of cap yomogi will be dissolved in 10 ml of water. The control group will receive Chickpea flour powder as a single dose per day. Chickpea flour powder is produced by Tarkhineh Company under the license No. 640920 and Operation license No.81, Tehran, Iran. For easier eating, the Chickpea flour powder will be dissolved in 10 ml of water. The color ,taste and volume of Chickpea flour powder will be similar of cap Yomogi. Frequency of diarrhea. Timepoint: before intervention, afterintervention. Method of measurement: questionnaire. Duration of diarrhea. Timepoint: before intervention, after intervention. Method of measurement: questionnaire. Qazvin University of Medical Sciences Approved 2017-09-02 ethics committee of Qazvin University of Medical Sciences Bolvar Shahid Bahonar,Qazvin University of medical sciences-Qazvin Qazvin Iran (Islamic Republic of)